Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Moxonidine and perindopril in hypertension and metabolic syndrome
NCT04023565Phase 4Unknown
- Start
- Mar 2019
- Primary completion
- Jun 2020
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of perindopril, moxonidine in hypertension (HTN), metabolic syndrome. Status: unknown.
02
Drugs
perindoprilmoxonidine
03
Conditions
hypertension (HTN)metabolic syndrome
Beyond the preview
Go deeper on NCT04023565.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04023565.